ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,440,547, issued on Oct. 14, was assigned to University of Maryland, Baltimore (Baltimore) and National Research Council of Canada (Ottawa).

"Live salmonella typhi vectors engineered to express heterologous outer membrane protein antigens and methods of use thereof" was invented by James E. Galen (Eldersburg, Md.), Thanh Pham (Baltimore), Dacie R. Bridge (Blairsville, Pa.), Jin Yuan Wang (Silver Spring, Md.) and Wangxue Chen (Ottawa).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compositions and methods of inducing an immune response in a subject in need thereof, comprising administering to the subject an immunologically-ef...